Winship Cancer Institute of Emory University members will present research, chair and moderate sessions and receive awards at the 2022 American Society of Clinical Oncology Annual Meeting taking place virtually and in Chicago June 3-7, 2022. This year's meeting will feature nearly 3,000 research abstracts focused on the theme: Advancing Equitable Cancer Care Through Innovation.
Expert Winship faculty, staff and trainees will participate in a variety of different sessions as chairs, moderators, speakers and awardees during the meeting.
A breast cancer clinical trial called MAINTAIN and led by Kevin Kalinsky, MD, MS, has been selected for the 2022 Best of ASCO program. Kalinsky, who is the director of the Glenn Family Breast Center and breast medical oncology program at Winship, the Louisa and Rand Glenn Family Chair in Breast Cancer Research and associate professor in the Emory Department of Hematology and Medical Oncology, is the first author of the study, "A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC)". Faculty invited to the program will present and discuss Kalinsky's abstract in a disease-specific session following the ASCO annual meeting.
On Friday, Nabil F. Saba, MD, co-director of Winship's Head and Neck Cancers Multi-Disciplinary Program, professor and vice chair for Quality and Safety in the Emory Department of Hematology and Medical Oncology and the Lynne and Howard Halpern Chair in Head and Neck Cancer Research, will present results from a phase II trial examining pembrolizumab and cabozantinib in patients with recurrent metastatic head and neck squamous cell carcinoma.
Also on Friday, several Winship faculty and trainees will be honored during the Conquer Cancer Foundation Ceremony and Reception held in the Hyatt Regency McCormick Place Regency Ballroom. Mylin A. Torres, MD, Winship co-leader of the Cancer Prevention and Control Research Program and professor of radiation oncology, will be awarded the Research Professorship for Diversity and Inclusion in Breast Cancer. Two Winship trainees, hematology and medical oncology fellow Ralph Millet, MD, and radiation oncology physician resident David C. Qian, MD, PhD, will receive the Young Investigator Award, which provides research funding to physicians during their final year of training to support their transition to a faculty appointment and encourage quality research in clinical oncology. Radiation oncology physician resident James Janopaul-Naylor, MD, will be recognized for the quality of the research he submitted for this year's ASCO meeting.
Sagar Lonial, MD, Winship chief medical officer, professor and chair of the Emory Department of Hematology and Medical Oncology and the Anne and Bernard Gray Family Chair in Cancer, will present "Synergistic effects of low-dose belantamab mafodotin in combination with a gamma-secretase inhibitor (nirogacestat) in patients with relapsed/refractory multiple myeloma (RRMM): DREAMM-5 study," on Saturday, June 5. Also on Saturday, Jill M. Binkley, PT, MSc, CLT, program director of the Atlanta non-profit organization TurningPoint, will present the results of her research project on racial disparities in breast cancer survivorship, which was funded by a 2021 community mini grant from Winship's Office of Community Outreach and Engagement.
On Monday during a poster session, Suresh Ramalingam, MD, Winship executive director, the Roberto C. Goizueta Distinguished Chair for Cancer Research and professor of hematology and medical oncology, will present results from a phase II study of tarlatamab, a DLL3-targeting immuno-oncology therapy for patients with relapsed/refractory small cell lung cancer. Olatunji B. Alese, MD, Winship director of Gastrointestinal Oncology, associate medical director of Winship’s Ambulatory Infusion Center and associate professor of hematology and medical oncology, will serve as a discussant during the Clinical Science Symposium focused on exploring barriers to workplace equity in Africa. Wendy Baer, MD, Winship director of psychiatric oncology and assistant professor in the Departments of Psychiatry and Behavioral Sciences and Hematology and Medical Oncology, will moderate a case-based panel titled "Loneliness: A Forgotten Challenge in Cancer Care." Jonathan L. Kaufman, MD, medical director and section chief of Winship's Ambulatory Infusion Centers and professor in the Emory Department or Hematology and Medical Oncology, will present "Highlights of the Hematologic Malignancies – Plasma Cell Dyscrasia Track" during a special session.
During the education sessions held throughout the conference Olatunji B. Alese, MD, will chair the session on the "Role of ctDNA in Adjuvant and Metastatic Therapy for Gastrointestinal Cancers"; Winship member Martha Arellano, MD, professor in the Emory Department of Hematology and Medical Oncology and associate director of the Division of Hematology, will present during the Training Program Directors’ Breakfast on Reviewing and Selecting Applicants for Interviews; Ajay K. Nooka, MD, MPH, medical director of the Winship Data and Technology Applications Shared Resource and associate professor in the Emory Department of Hematology and Medical Oncology and director of its Myeloma program, will chair the session on "The Role of Measurable Residual Disease Testing in Myeloma in the Quest for Cure"; and Bree R. Eaton, MD, pediatric medical director of Winship's Emory Proton Therapy Center and assistant professor in the Emory Department of Radiation Oncology, will present on "Modifying Radiotherapy to Reduce Late Effects in Medulloblastoma."
Winship research was featured in other sessions as well. ASCO poster sessions will be available online for viewing on the day of presentation. View the schedule of oral abstract and poster sessions by Winship faculty, staff and trainees at the link below.